A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials

Frontiers in Psychology

Volumn 6, Issue JUN, 2015, Pages

  de Sola, Susana ^a,b   de la Torre, Rafael ^a,c,d   Sánchez Benavides, Gonzalo ^a   Benejam, Bessy ^e   Cuenca Royo, Aida ^a   del Hoyo, Laura ^a   Rodríguez, Joan ^a   Catuara Solarz, Silvina ^b   Sanchez Gutierrez, Judit ^f   Dueñas Espin, Ivan ^a,d   Hernandez, Gimena ^a,g   Peña Casanova, Jordi ^a   Langohr, Klaus ^a,h   Videla, Sebastia ^e   Blehaut, Henry ⁱ   Farre, Magi ^a,g   Dierssen, Mara ^b,j   Principe, Alessandro ^a   Civit, Ester ^a   Pujol, Jesús ^k   Espadaler, Josep Ma ^a   Trias, Katy ^l   Roca, Laia ^a   Blanco, Laura ^a   Xicota, Laura ^a   Freixas, Rut ^b   Legout, Valérie ^m   more..

^a HOSPITAL DEL MAR   (Spain)

^b CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e Fundacio Catalana Sindrome de Down   (Spain)

^f Fundació Privada Espai Salut   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

ⁱ Institut Jerome Lejeune   (France)

^j CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^k Neurovoxel   (Spain)

^l Down Syndrome Catalan Foundation   (Spain)

^m Institut Jerome Lejeune   (France)

more..

Author keywords

Clinical trials as topic; Cognition; Down syndrome; Intellectual disabilities; TESDAD neurocognitive battery

Indexed keywords

EID: 84940557032     PISSN: None     EISSN: 16641078     Source Type: Journal    
DOI: 10.3389/fpsyg.2015.00708     Document Type: Article

References (52)

1. Abbeduto, L., Pavetto, M., Kesin, E., Weissman, M. D., Karadottir, S., O'Brien, A., et al. (2001). The linguistic and cognitive profile of Down syndrome: evidence from a comparison with fragile X syndrome. Downs. Syndr. Res. Pract. 7, 9-15. doi: 10.3104/reports.109.
2. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th Edn. Washington, DC: American Psychiatric Association.
3. Ball, S. L., Holland, A. J., Treppner, P., Watson, P. C., and Huppert, F. A. (2008). Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities. Br. J. Clin. Psychol. 47, 1-29. doi: 10.1348/014466507X230967.
4. Beacher, F., Simmons, A., Daly, E., Prasher, V., Adams, C., Margallo-Lana, M. L., et al. (2005). Hippocampal myo-inositol and cognitive ability in adults with Down syndrome: an in vivo proton magnetic resonance spectroscopy study. Arch. Gen. Psychiatry 62, 1360-1365. doi: 10.1001/archpsyc.62.12.1360.
5. Bisegger, C., Cloetta, B., von Rueden, U., Abel, T., and Ravens-Sieberer, U. (2005). Health-related quality of life: gender differences in childhood and adolescence. Soz. Praventivmed. 50, 281-291. doi: 10.1007/s00038-005-4094-2.
6. Blumenfeld, R. S., Parks, C. M., Yonelinas, A. P., and Ranganath, C. (2011). Putting the pieces together: the role of dorsolateral prefrontal cortex in relational memory encoding. J. Cogn. Neurosci. 23, 257-265. doi: 10.1162/jocn.2010.21459.
7. Boada, R., Hutaff-Lee, C., Schrader, A., Weitzenkamp, D., Benke, T. A., Goldson, E. J., et al. (2012). Antagonism of NMDA receptors as a potential treatment for Down syndrome: a pilot randomized controlled trial. Transl. Psychiatry 2, e141. doi: 10.1038/tp.2012.66.
8. Braver, T. S. (2001). Anterior cingulate cortex and response conflict: effects of frequency, inhibition and errors. Cereb. Cortex 11, 825-836. doi: 10.1093/cercor/11.9.825.
9. Carducci, F., Onorati, P., Condoluci, C., Di Gennaro, G., Quarato, P. P., Pierallini, A., et al. (2013). Whole-brain voxel-based morphometry study of children and adolescents with Down syndrome. Funct. Neurol. 28, 19-28. doi: 10.11138/FNeur/2013.28.1.019.
10. Choen, J. (1988). Statistical Power Analysis for the Behavioral Sciences, 2nd Edn. Hillsdale: Lawrence Erlbaum Associates.
11. Contestabile, A., Benfenati, F., and Gasparini, L. (2010). Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome. Prog. Neurobiol. 91, 1-22. doi: 10.1016/j.pneurobio.2010.01.003.
12. Costa, A. C. S. (2011). On the promise of pharmacotherapies targeted at cognitive and neurodegenerative components of Down syndrome. Dev. Neurosci. 33, 414-427. doi: 10.1159/000330861.
13. Costanzo, F., Varuzza, C., Menghini, D., Addona, F., Gianesini, T., and Vicari, S. (2013a). Executive functions in intellectual disabilities: a comparison between Williams syndrome and Down syndrome. Res. Dev. Disabil. 34, 1770-1780. doi: 10.1016/j.ridd.2013.01.024.
14. Costanzo, F., Vicari, S., and Carlesimo, G. A. (2013b). Familiarity and recollection in Williams syndrome. Cortex 49, 232-242. doi: 10.1016/j.cortex.2011.06.007.
15. Culbertson, W., and Zillmer, E. (2005). Tower of London Drexel University: 2nd Edn (TOL DX): Technical Manual, 2nd Edn. New York, NY: Multi-Health Systems Inc.
16. De la Torre, R., De Sola, S., Pons, M., Duchon, A., de Lagran, M. M., Farré, M., et al. (2014). Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. Mol. Nutr. Food Res. 58:278288. doi: 10.1002/mnfr.201300325.
17. Devenny, D. A., Zimmerli, E. J., Kittler, P., and Krinsky-McHale, S. J. (2002). Cued recall in early-stage dementia in adults with Down's syndrome. J. Intellect. Disabil. Res. 46, 472-483. doi: 10.1046/j.1365-2788.2002.00417.x.
18. Edgin, J. O., Mason, G. M., Allman, M. J., Capone, G. T., Deleon, I., Maslen, C., et al. (2010a). Development and validation of the Arizona Cognitive Test Battery for Down syndrome. J. Neurodev. Disord. 2, 149-164. doi: 10.1007/s11689-010-9054-3.
19. Edgin, J. O., Pennington, B. F., and Mervis, C. B. (2010b). Neuropsychological components of intellectual disability: the contributions of immediate, working, and associative memory. J. Intellect. Disabil. Res. 54, 406-417. doi: 10.1111/j.1365-2788.2010.01278.x.
20. Ersche, K. D., Turton, A. J., Chamberlain, S. R., Müller, U., Bullmore, E. T., and Robbins, T. W. (2012). Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. Am. J. Psychiatry 169, 926-936. doi: 10.1176/appi.ajp.2012.11091421.
21. Ferrer, I., and Gullotta, F. (1990). Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus. Acta Neuropathol. 79, 680-685. doi: 10.1007/BF00294247.
22. Finestack, L. H., and Abbeduto, L. (2010). Expressive language profiles of verbally expressive adolescents and young adults with Down syndrome or fragile X syndrome. J. Speech. Lang. Hear. Res. 53, 1334-1348. doi: 10.1044/1092-4388(2010/09-0125).
23. Iacono, T., Torr, J., and Wong, H. Y. (2010). Relationships amongst age, language and related skills in adults with Down syndrome. Res. Dev. Disabil. 31, 568-576. doi: 10.1016/j.ridd.2009.12.009.
24. Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., et al. (2010). Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 167, 748-751. doi: 10.1176/appi.ajp.2010.09091379.
25. Insel, T., Krystal, J., and Ehlers, M. (2013). New drug development for cognitive enhancement in mental health: challenges and opportunities. Neuropharmacology 64, 2-7. doi: 10.1016/j.neuropharm.2012.07.041.
26. Juncos-Rabadán, O., Facal, D., Pereiro, A. X., and Lojo-Seoane, C. (2014). Visual memory profiling with CANTAB in mild cognitive impairment (MCI) subtypes. Int. J. Geriatr. Psychiatry 29, 1040-1048. doi: 10.1002/gps.4095.
27. Khoshnood, B., Greenlees, R., Loane, M., Dolk, H., Committee, E. P. M., and Group, E. W. (2011). Paper 2: EUROCAT public health indicators for congenital anomalies in Europe. Birth Defects Res. A Clin. Mol. Teratol. 91(Suppl. 1), S16-S22. doi: 10.1002/bdra.20776.
28. Krasuski, J. S., Alexander, G. E., Horwitz, B., Rapoport, S. I., and Schapiro, M. B. (2002). Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease. Am. J. Psychiatry 159, 74-81. doi: 10.1176/appi.ajp.159.1.74.
29. Lanfranchi, S., Cornoldi, C., and Vianello, R. (2004). Verbal and visuospatial working memory deficits in children with Down syndrome. Am. J. Ment. Retard. 109, 456-466. doi: 10.1352/0895-8017(2004)109<456:VAVWMD>2.0.CO;2.
30. Lanfranchi, S., Jerman, O., Dal Pont, E., Alberti, A., and Vianello, R. (2010). Executive function in adolescents with Down Syndrome. J. Intellect. Disabil. Res. 54, 308-319. doi: 10.1111/j.1365-2788.2010.01262.x.
31. Laws, G., and Bishop, D. V. M. (2004). Verbal deficits in Down's syndrome and specific language impairment: a comparison. Int. J. Lang. Commun. Disord. 39, 423-451. doi: 10.1080/13682820410001681207.
32. Lott, I. T., and Dierssen, M. (2010). Cognitive deficits and associated neurological complications in individuals with Down's syndrome. Lancet Neurol. 9, 623-633. doi: 10.1016/S1474-4422(10)70112-5.
33. Lund, J. (1988). Psychiatric aspects of Down's syndrome. Acta Psychiatr. Scand. 78, 369-374. doi: 10.1111/j.1600-0447.1988.tb06350.x.
34. Määttä, T., Tervo-Määttä, T., Taanila, A., Kaski, M., and Iivanainen, M. (2006). Mental health, behaviour and intellectual abilities of people with Down syndrome. Downs. Syndr. Res. Pract. 11, 37-43. doi: 10.3104/reports.313.
35. Megarbane, A., Ravel, A., Mircher, C., Sturtz, F., Grattau, Y., Rethore, M. O., et al. (2009). The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome. Genet. Med. 11, 611-616. doi: 10.1097/GIM.0b013e3181b2e34c.
36. Michel, G., Bisegger, C., Fuhr, D. C., and Abel, T. (2009). Age and gender differences in health-related quality of life of children and adolescents in Europe: a multilevel analysis. Qual. Life Res. 18, 1147-1157. doi: 10.1007/s11136-009-9538-3.
37. Næss, K.-A. B., Lyster, S.-A. H., Hulme, C., and Melby-Lervåg, M. (2011). Language and verbal short-term memory skills in children with Down syndrome: a meta-analytic review. Res. Dev. Disabil. 32, 2225-2234. doi: 10.1016/j.ridd.2011.05.014.
38. Peña-Casanova, J., Casals-Coll, M., Quintana, M., Sánchez-Benavides, G., Rognoni, T., Calvo, L., et al. (2012). [Spanish normative studies in a young adult population (NEURONORMA young adults Project): methods and characteristics of the sample]. Neurologia 27, 253-260. doi: 10.1016/j.nrl.2011.12.019.
39. Pennington, B. F., Moon, J., Edgin, J., Stedron, J., and Nadel, L. (2003). The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. Child Dev. 74, 75-93. doi: 10.1111/1467-8624.00522.
40. Raz, N., Torres, I. J., Briggs, S. D., Spencer, W. D., Thornton, A. E., Loken, W. J., et al. (1995). Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry. Neurology 45, 356-366. doi: 10.1212/WNL.45.2.356.
41. Robbins, T. W., James, A., Owen, A. M., Sahakian, B. J., McInnes, L., and Rabbitt, P. M. A. (1997). "A neural systems approach to the cognitive psychology of ageing using the CANTAB battery:Studies with CANTAB on a large sample of the normal elderly population," in Methodology of Frontal and Executive Function, ed. P. Rabbitt, 215-238.
42. Robbins, T. W., James, M., Owen, A. M., Sahakian, B. J., Lawrence, A. D., McInnes, L., et al. (1998). A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. J. Int. Neuropsychol. Soc. 4, 474-490. doi: 10.1017/s1355617798455073.
43. Robbins, T. W., and Sahakian, B. (1996). Cambridge Neuropsychological Test Automated Battery. Available online at: http://www.cambridgecognition.com/technology.
44. Rowe, J., Lavender, A., and Turk, V. (2006). Cognitive executive function in Down's syndrome. Br. J. Clin. Psychol. 45, 5-17. doi: 10.1348/014466505X29594.
45. Strauss, E., Sherman, E. M. S., and Spreen, O. (2006). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press.
46. Takashima, S., Iida, K., Mito, T., and Arima, M. (1994). Dendritic and histochemical development and ageing in patients with Down's syndrome. J. Intellect. Disabil. Res. 38(Pt 3), 265-273. doi: 10.1111/j.1365-2788.1994.tb00394.x.
47. Takeuchi, H., Taki, Y., Nouchi, R., Hashizume, H., Sassa, Y., Sekiguchi, A., et al. (2014). Anatomical correlates of quality of life: evidence from voxel-based morphometry. Hum. Brain Mapp. 35, 1834-1846. doi: 10.1002/hbm.22294.
48. Teipel, S. J., Alexander, G. E., Schapiro, M. B., Moller, H. J., Rapoport, S. I., and Hampel, H. (2004). Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry. Brain 127, 811-824. doi: 10.1093/brain/awh101.
49. Torsheim, T., Ravens-Sieberer, U., Hetland, J., Välimaa, R., Danielson, M., and Overpeck, M. (2006). Cross-national variation of gender differences in adolescent subjective health in Europe and North America. Soc. Sci. Med. 62, 815-827. doi: 10.1016/j.socscimed.2005.06.047.
50. Vicari, S. (2006). Motor development and neuropsychological patterns in persons with Down syndrome. Behav. Genet. 36, 355-364. doi: 10.1007/s10519-006-9057-8.
51. Wager, T. D., and Smith, E. E. (2003). Neuroimaging studies of working memory: a meta-analysis. Cogn. Affect. Behav. Neurosci. 3, 255-274. doi: 10.3758/CABN.3.4.255.
52. White, N. S., Alkire, M. T., and Haier, R. J. (2003). A voxel-based morphometric study of nondemented adults with Down Syndrome. Neuroimage 20, 393-403. doi: 10.1016/S1053-8119(03)00273-8.